Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

Kevin L. Winthrop, Gustavo Citera, David Gold, Dan Henrohn, Carol A. Connell, Andrea B. Shapiro, Harry Shi, Alina M. Onofrei, Dimitrios A. Pappas, Hendrik Schulze-Koops

Research output: Contribution to journalLetterpeer-review

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalAnnals of the rheumatic diseases
Issue number1
StatePublished - Jan 1 2021


  • adalimumab
  • antirheumatic agents
  • arthritis
  • biological therapy
  • rheumatoid
  • tumor necrosis factor inhibitors

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this